AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
ALX Oncology Holdings Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00VR8SF73
1.17▼ 0.02 (-1.68%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
1.19
Day's Range
1.10 – 1.23
52-Week Range
0.86 – 2.66
Volume
547.5K
Avg Volume
1.4M
Share Statistics
Shares Outstanding
Employees
43
Exchange
XNAS
Listed
2020-07-17
Share count as of July 30, 2026

ALX Oncology Holdings Inc. Common Stock (ALXO) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about ALX Oncology Holdings Inc. Common Stock (ALXO)
What is ALX Oncology Holdings Inc. Common Stock's Market Cap?
ALX Oncology Holdings Inc. Common Stock's Market Cap is $161.8M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Enterprise Value?
ALX Oncology Holdings Inc. Common Stock's Enterprise Value is $34.3M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's EV / EBITDA?
ALX Oncology Holdings Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Net Income (TTM)?
ALX Oncology Holdings Inc. Common Stock's Net Income (TTM) is -$80.9M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's EBITDA?
ALX Oncology Holdings Inc. Common Stock's EBITDA is -$82.0M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Diluted EPS (TTM)?
ALX Oncology Holdings Inc. Common Stock's Diluted EPS (TTM) is -0.58, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Net Debt?
ALX Oncology Holdings Inc. Common Stock's Net Debt is -$127.4M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ALXOAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Lease termination (gain) and impairment charge———
Total operating expenses
Loss from operations
Interest income
Interest expense
Other expense, net
Loss on debt extinguishment———
Net loss
Net loss per share, basic
Net loss per share, diluted